Contract Pharmaceuticals Limited

Wishing all our many US customers and friends a very Happy Independence Day today. We are grateful of the friendship our countries share and wish all of you a celebratory July 4th!

Last month at the CPHI North America conference, David Tyler sat down with Contract Pharma to discuss the recent change in ownership of CPL, including CPL's continued commitment to customers and partners, our technical capabilities, and our global market presence. 👇Click the link below to watch a short video summary of the discussion👇

CPL is pleased to share that Aterian Investment Partners, a private investment firm, has closed its acquisition of Contract Pharmaceuticals Limited Canada (CPL), a leading North American contract development and manufacturing organization (CDMO) of non-sterile liquid and semi-solid dosage forms. “We are excited to have successfully closed this transaction. With Aterian’s investment in people, technology and processes, CPL is equipped and ready to enter its next phase of growth and to drive  industry transformation by providing further value to customers,” said the Aterian team. https://lnkd.in/gQ3J_G7A

CPL is pleased to share that Aterian Investment Partners, a private investment firm, has closed its acquisition of Contract Pharmaceuticals Limited Canada (CPL), a leading North American contract development and manufacturing organization (CDMO) of non-sterile liquid and semi-solid dosage forms. “We are excited to have successfully closed this transaction. With Aterian’s investment in people, technology and processes, CPL is equipped and ready to enter its next phase of growth and to drive  industry transformation by providing further value to customers,” said the Aterian team. https://lnkd.in/gQ3J_G7A

Reflecting on an exciting week in Philadelphia at CPHI North America! Thank you to all of our customers and new connections for taking the time to meet with us. We look forward to putting our discussions into action in the coming weeks! ✔

Today, on World Earth Day 2024, we are reminded of the responsibility we carry towards our planet and future generations. At CPL, we stand firm in our commitment to sustainability, recognizing that every action we take today shapes the world of tomorrow. Happy World Earth Day! 🌎 #WorldEarthDay #Sustainability #GreenFuture #CorporateResponsibility

Seeking a CDMO for your topical, nasal spray, or non-sterile liquid drug development/manufacturing project? Meet with us during the upcoming CPHI North America conference to learn more about how we can support your needs. Visit us at booth #659 or click the following link to schedule a meeting with us!: https://lnkd.in/dFgnmQHi

CPL's Senior Director of Product Development, Brian Lankadurai, recently sat down to discuss our integrated approach to topical drug formulation and analytical development utilizing our in-house IVRT and IVPT skin testing expertise 🔬. Click below to watch the short video of that discussion 📽: https://lnkd.in/g8pCMuqF

We are very pleased to announce that an affiliate of Aterian Investment Partners, a Miami and New York-based private investment firm, has signed an agreement to recapitalize Contract Pharmaceuticals Limited Canada with the intent to continue operations in Mississauga, Ontario. We are thrilled to enter this new chapter with Aterian, which has a demonstrated history of supporting companies with a focus on product innovation and partnership. Please click the following link to view the full Press Release: https://https://lnkd.in/gqgtbbGe

To our partners and colleagues who celebrate, CPL wishes you a Happy Easter! May this special day bring you and your loved ones renewal and happiness.🐇